4//SEC Filing
Anglin Robert M 4
Accession 0001209191-13-013293
CIK 0000868368other
Filed
Mar 3, 7:00 PM ET
Accepted
Mar 4, 4:39 PM ET
Size
14.7 KB
Accession
0001209191-13-013293
Insider Transaction Report
Form 4
Anglin Robert M
VP Quality & Regulatory
Transactions
- Exercise/Conversion
Common Stock
2013-03-01$4.63/sh+4,000$18,500→ 14,600 total - Exercise/Conversion
Stock Option (Right to Buy)
2013-03-01−4,000→ 0 totalExercise: $4.63Exp: 2014-01-02→ Common Stock (4,000 underlying) - Sale
Common Stock
2013-03-01$14.70/sh−4,000$58,800→ 10,600 total
Holdings
- 5,000
Stock Option (Right to Buy)
Exercise: $10.89From: 2009-02-12Exp: 2018-02-12→ Common Stock (5,000 underlying) - 10,000
Stock Option (Right to Buy)
Exercise: $12.27From: 2011-01-28Exp: 2020-01-28→ Common Stock (10,000 underlying) - 10,000
Stock Option (Right to Buy)
Exercise: $11.91From: 2007-11-29Exp: 2016-11-29→ Common Stock (10,000 underlying) - 20,000
Stock Option (Right to Buy)
Exercise: $11.27From: 2010-02-03Exp: 2019-02-03→ Common Stock (20,000 underlying) - 10,000
Stock Option (Right to Buy)
Exercise: $10.72From: 2012-01-27Exp: 2021-01-27→ Common Stock (10,000 underlying)
Footnotes (1)
- [F1]Vest as to 25% annual cumulative installments beginning one year from date of grant, beginning the date shown.
Documents
Issuer
ROCHESTER MEDICAL CORPORATION
CIK 0000868368
Entity typeother
Related Parties
1- filerCIK 0001450690
Filing Metadata
- Form type
- 4
- Filed
- Mar 3, 7:00 PM ET
- Accepted
- Mar 4, 4:39 PM ET
- Size
- 14.7 KB